This study aims to assess the recovery kinetics following an exercise-induced muscle damage activity (using flywheel) on active healthy university students. The main questions are: \- Is intermittent pneumatic compression superior to a placebo recovering from EIMD? Participants will perform a fatiguing protocol using flywheel and recover with either intermittent pneumatic compression or with a placebo treatment (micro-current treatment, but the device turned off). They will perform several performance tests before, following the recovery period, and at the 24h and 48h following the intervention
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
33
A 30 min IPC protocol at about 200mmHg
The electrodes of an electrostimulation device (SP 4.0, Compex, Guildford, United Kingdom) will be positioned on participants' quadriceps. Participants will be informed that they are engaging an innovative microcurrent treatment. This procedure will last for 30 min.
University of Maia
Maia, Portugal
Maximal voluntary contraction (knee extension)
Measures of isometric strength
Time frame: 10 minutes before the fatigue protocol, following the recovery protocol (30 minutes post), 24 hours and 48 hours post intervention
Countermovement jump
Jump height
Time frame: 10 minutes before the fatigue protocol, following the recovery protocol (30 minutes post), 24 hours and 48 hours post intervention
Broad Jump
Horizontal jump
Time frame: 10 minutes before the fatigue protocol, following the recovery protocol (30 minutes post), 24 hours and 48 hours post intervention
Soreness scale
Likert scale of muscle soreness - the scale ranges from from 0 (a complete absence of soreness) to 6 (a severe pain that limits the ability to move)
Time frame: 10 minutes before the fatigue protocol, following the recovery protocol (30 minutes post), 24 hours and 48 hours post intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.